Cipla Ltd

NSE: CIPLA · Pharmaceuticals · sector

₹1,355.00NSE close 2026-10-26

Key numbers

Market cap₹1,09,464 cr

Price₹1,355.00

52w high / low₹1,673 / ₹1,166

P/E32.5xSector median 27.9x

P/B3.2xSector median 2.9x

Book value₹426.2

Dividend yield1.18%Sector median 0.48%

ROE10.3%Sector median 11.7%

ROCE13.2%Sector median 12.3%

OPM17.7%Sector median 14.0%

Debt / equity0.01xSector median 0.16x

EV/EBITDA20.1xSector median 18.6x

Interest cover80.1x

Current ratio3.44x

Sales growth 3y+7.4%Sector median +9.6%

Profit growth 3y+11.4%Sector median +13.3%

PEG2.85x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹8,987 cr vs borrowings ₹258 cr (FY26): cash is higher (net cash).
Operating profit covered interest 80.1x in the last 12 months.
No promoter shares are pledged.
Operating cash flow was below net profit in 1 of the last 5 years (FY25).
Revenue was higher than a year earlier in 3 of the last 4 quarters.
Other income was 25% of net profit in the last 12 months.
Dividend paid in 5 of the last 5 financial years.
Price ₹1,355.00 on 2026-10-26: -19.0% from the 52-week high, +16.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹1,658.15 · low ₹1,195.90

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	7,051	7,073	6,730	6,957	7,589	7,074	6,541	7,119
EBITDA	1,886	1,989	1,538	1,778	1,895	979	955	1,192
OPM %	26.7%	28.1%	22.8%	25.6%	25.0%	13.8%	14.6%	16.7%
Other income	191	222	289	259	269	206	148	211
Net profit	1,303	1,571	1,222	1,298	1,351	676	555	789
EPS (₹)	16.13	19.45	15.13	16.07	16.73	8.37	6.87	9.77
Revenue YoY					+7.6%	+0.0%	-2.8%	+2.3%
Profit YoY					+3.7%	-57.0%	-54.6%	-39.2%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	21,763	22,753	25,774	27,548	28,163	28,324
EBITDA	4,371	4,845	6,096	7,128	5,607	5,021
Net profit	2,517	2,802	4,122	5,273	3,879	3,371
EPS (₹)	31.20	34.72	51.05	65.29	48.03	41.74
Revenue growth		+4.5%	+13.3%	+6.9%	+2.2%	+1.9%
Profit growth		+11.3%	+47.1%	+27.9%	-26.4%	-37.5%
Dividend / share (₹)	5.00	5.00	8.50	13.00	13.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+7.4%	+8.0%	+1.8%
Net profit	+11.5%	+10.0%	-37.5%
EPS	+11.4%	+10.0%	–
Share price	–	-7.1% (2y)	-21.0%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	23,408	26,706	31,193	34,432
Borrowings	–	520	247	92	258
Cash & equivalents	–	4,654	5,682	8,093	8,987
Total assets	–	29,463	32,718	37,387	42,496
Fixed assets	–	4,991	5,069	5,262	6,040
Capital work in progress	–	689	864	1,213	1,586
Investments	–	482	512	499	432
Receivables	–	4,057	4,771	5,506	5,620
Inventory	–	5,156	5,238	5,642	6,597
Payables	–	2,457	2,474	2,837	3,230

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	3,326	3,238	4,134	5,005	3,940
Cash from investing	-1,872	-2,389	-2,988	-3,691	-2,326
Cash from financing	-1,600	-958	-1,200	-1,293	-1,234
Capex	701	1,183	1,349	1,548	3,079
Free cash flow	2,625	2,055	2,785	3,457	861

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	12.0%	15.4%	16.9%	11.3%
ROCE %	–	17.3%	21.5%	22.0%	15.2%
Debtor days	–	65	68	73	73
Inventory days	–	228	217	231	252
Payable days	–	109	102	116	123
Cash conversion cycle (days)	–	184	183	188	202
Working capital days	–	189	200	235	222

Shareholding

Holder	% (2026-09-30)
Promoters	29.21%
FIIs	20.25%
DIIs	34.94%
of which Mutual funds	20.78%
of which Insurance	11.69%
Government	0.00%
Public (non-institutions)	15.60%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	29.19%	29.20%	29.19%	29.21%	29.21%	29.21%	29.21%	29.21%

Promoter group	%
Yusuf Khwaja Hamied	18.68%
Sophie Ahmed	5.71%
M K Hamied	3.46%
Kamil Hamied	1.36%
Samina Hamied	0.00%
Rumana Hamied	0.00%
Shirin Hamied	0.00%
MN Rajkumar Garments LLP	0.00%
Shree Riddhi Chemicals LLP	0.00%
Alps Remedies Private Limited	0.00%
Hamsons Laboratories LLP	0.00%
Okasa Pharma Private Limited	0.00%
Healing Cross Pharma Private Limited	0.00%
NCE Research Labs Private Limited	0.00%
Uniworld Pharma Private Limited	0.00%

Public holders above 1%	%
Lici Ulip-growth Fund	9.59%
HDFC Mutual Fund - HDFC Focused Fund	4.03%
SBI Elss TAX Saver Fund	3.41%
ICICI Prudential Nifty50 Equal Weight Index Fund	2.89%
Nippon Life India Trustee Ltd-a/c Nippon India ARB	2.03%
Parag Parikh Arbitrage Fund	1.86%
DSP Flexi CAP Fund	1.82%
NPS Trust -A/C LIC Pension Fund Limited APY Fund S	1.79%
Government Pension Fund Global	1.23%
Vanguard Total International Stock Index Fund	1.05%
Vanguard Emerging Markets Stock Index Fund, A Seri	1.01%

5,62,798 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
LUPIN	₹89,616 cr	16.2x	4.0x	27.9%	27.9%	30.0%	+18.9%	0.61%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-06-05	Dividend	Dividend - Rs 13 Per Share
2025-06-27	Dividend	Dividend - Rs 13 Per Share/Special Dividend - Rs 3 Per Share
2024-08-02	Dividend	Dividend - Rs 13 Per Share
2023-07-21	Dividend	Dividend - Rs 8.50 Per Share
2022-08-08	Dividend	Dividend - Rs 5 Per Share
2021-08-09	Dividend	Annual General Meeting/Dividend - Rs 5 Per Share
2020-08-11	Other	Annual General Meeting
2020-03-19	Dividend	Interim Dividend - Rs 3 Per Share Special Dividend - Re 1 Per Share
2019-07-31	Dividend	Annual General Meeting/Dividend - Rs 3 Per Share
2018-08-13	Dividend	Annual General Meeting/Dividend- Rs 3 Per Share
2017-07-26	Dividend	Annual General Meeting/Dividend - Rs 2/- Per Share
2016-09-12	Dividend	Annual General Meeting/Dividend Rs 2/- Per Share
2015-08-11	Dividend	Annual General Meeting/Dividend - Rs 2/- Per Share
2014-08-06	Dividend	Annual General Meeting/Dividend Rs 2/- Per Equity Share
2013-08-06	Dividend	Annual General Meeting/Dividend Rs 2/- Per Equity Share
2012-08-01	Dividend	Annual General Meeting And Dividend - Rs.2/- Per Share
2011-08-09	Dividend	Annual General Meeting And Dividend Rs.2/- Per Share
2010-09-03	Dividend	Special Interim Dividend Re.0.80 Per Share
2010-07-23	Dividend	Annual General Meeting And Dividend Rs.2/- Per Share
2009-08-10	Other	Agm/Div-Rs.2/- Per Share

Documents

Links go to the original files on the exchange website.

About the company

Trade: Wholesale Trading
Manufacturing: Manufacture of pharmaceuticals, medicinal chemical and botanical products


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	CIPLA
BSE code	500087
ISIN	INE059A01026
Face value	₹2.0
Incorporated	1935-08-17
Website	www.cipla.com
Plants (India / abroad)	39 / 9

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.